Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1502 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Teva Pharma Q2 Sales Up 12%

Teva Pharma has posted a net income of $800m for the second quarter 2010, or $ 0.88 per diluted share, compared to $523m or $0.58 per diluted share

LAB Research Signs PRA With Japanese Pharma Firm

Additionally, LAB Research Canada is expected to provide program management resources, annual volume discounts, preferential scheduling and reporting timelines and other operational advantages. Luc Mainville, president and CEO

Novavax Gains US Patent For Influenza VLP Vaccines

Novavax’s newly patented influenza vaccine technology utilises hemagglutinin (HA) and neuraminidase (NA), major proteins found on the surface of the influenza virus together with a single influenza matrix

QPS Acquires Xendo Drug Development

With the completion of this acquisition, QPS further expands its linearly integrated resources and services which consists of drug discovery and development from preclinical to clinical studies for

GenomeQuest Names New Chief Marketing Officer

Flynn has worked as CMO at Bentley Systems, a provider of engineering software to the global infrastructure market. Flynn said that his immediate marketing plans for the company